For unresectable or metastatic liposarcoma or leiomyosarcoma after an anthracycline

Dosing and Administration

Recommended dosing and administration information for YONDELIS®

LEARN MORE

Mechanism of Action

Information on the mechanism of action for YONDELIS®

LEARN MORE

Treatment Considerations

Considerations for treating unresectable or metastatic liposarcoma and leiomyosarcoma, 2 of the most common subtypes of soft tissue sarcoma

LEARN MORE

Janssen CarePath Is Your One Source for Patient Support

Janssen CarePath provides resources to help your patients start and stay on the Janssen medications you prescribe

LEARN MORE

INDICATION AND IMPORTANT SAFETY INFORMATION

INDICATION AND IMPORTANT SAFETY INFORMATION

EXPAND Expand isi
Footer image